The blood pressure drug Olmesartan is linked to gastrointestinal issues such as nausea, vomiting, diarrhea and weight loss, U.S. researchers say. Dr. Joseph Murray, a gastroenterologist at the Mayo Clinic, said after he pulled several patients off Olmesartan their gastrointestinal symptoms dramatically improved. Eventually, all 22 were taken off the drug, and all showed improvement, Murraysaid. "We thought these cases were celiac disease initially because their biopsies showed features very like celiac disease, such as inflammation," Murray said in a statement. "What made them different was they didn't have the antibodies in their blood that are typical for celiac disease." Olmesartan -- prescribed for the treatment of hypertension, or high blood pressure -- works by blocking substances that tighten blood vessels, allowing blood to flow more smoothly and the heart to pump more efficiently, Murray said. "It's really an awareness issue. We want doctors to be aware of this issue, so if they see a patient who is having this type of syndrome -- they think about medications as a possible association," Murray said. "We've reported an association. What needs to be known next is the science to understand why there is such an association." The findings were published online in the medical journal Mayo Clinic Proceedings.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor